MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0779
-0.0061 (-7.26%)
May 14, 2026, 11:42 AM EST
MariMed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 161.4 | 159.83 | 157.71 | 148.6 | 134.01 | 121.46 | |
Revenue Growth (YoY) | 2.16% | 1.34% | 6.13% | 10.89% | 10.33% | 138.66% |
Cost of Revenue | 103.33 | 101.95 | 95.1 | 82.68 | 70.05 | 55.2 |
Gross Profit | 58.07 | 57.88 | 62.61 | 65.92 | 63.96 | 66.26 |
Selling, General & Admin | 59.04 | 58.63 | 59.39 | 50.72 | 38.88 | 37.54 |
Operating Expenses | 59.37 | 60.22 | 59.05 | 50.84 | 42.63 | 39.4 |
Operating Income | -1.3 | -2.33 | 3.56 | 15.08 | 21.33 | 26.86 |
Interest Expense | -7.72 | -7.5 | -6.94 | -9.19 | -1.69 | -2.36 |
Interest & Investment Income | 0.19 | 0.18 | 0.11 | 0.27 | 0.96 | 0.11 |
Other Non Operating Income (Expenses) | 0.08 | 0.08 | 0.1 | -0.65 | -0.05 | -0 |
EBT Excluding Unusual Items | -8.74 | -9.58 | -3.18 | 5.51 | 20.55 | 24.61 |
Merger & Restructuring Charges | -1.29 | -1.29 | -0.95 | -0.7 | -0.96 | - |
Gain (Loss) on Sale of Investments | - | - | -0.15 | -0.08 | -0.08 | -0.8 |
Gain (Loss) on Sale of Assets | - | - | - | -0.91 | - | - |
Other Unusual Items | 0.7 | - | - | -10.43 | - | - |
Pretax Income | -9.33 | -10.86 | -4.27 | -6.6 | 19.51 | 23.82 |
Income Tax Expense | 3.41 | 3.59 | 8.16 | 9.41 | 5.89 | 16.19 |
Earnings From Continuing Operations | -12.74 | -14.46 | -12.43 | -16.01 | 13.61 | 7.62 |
Minority Interest in Earnings | -0.01 | -0.03 | -0.04 | -0.02 | -0.15 | -0.4 |
Net Income | -12.76 | -14.48 | -12.47 | -16.03 | 13.47 | 7.23 |
Net Income to Common | -12.76 | -14.48 | -12.47 | -16.03 | 13.47 | 7.23 |
Net Income Growth | - | - | - | - | 86.41% | 236.99% |
Shares Outstanding (Basic) | 394 | 390 | 379 | 363 | 338 | 326 |
Shares Outstanding (Diluted) | 394 | 390 | 379 | 363 | 380 | 372 |
Shares Change (YoY) | 3.38% | 2.90% | 4.33% | -4.44% | 2.12% | 14.88% |
EPS (Basic) | -0.03 | -0.04 | -0.03 | -0.04 | 0.04 | 0.02 |
EPS (Diluted) | -0.04 | -0.04 | -0.03 | -0.04 | 0.04 | 0.02 |
EPS Growth | - | - | - | - | 99.41% | 149.07% |
Free Cash Flow | 6.08 | 6.53 | -5.18 | -12.22 | -4.83 | 17.98 |
Free Cash Flow Per Share | 0.01 | 0.02 | -0.01 | -0.03 | -0.01 | 0.05 |
Gross Margin | 35.98% | 36.22% | 39.70% | 44.36% | 47.73% | 54.55% |
Operating Margin | -0.80% | -1.46% | 2.26% | 10.15% | 15.92% | 22.12% |
Profit Margin | -7.90% | -9.06% | -7.90% | -10.79% | 10.05% | 5.95% |
Free Cash Flow Margin | 3.77% | 4.08% | -3.28% | -8.22% | -3.60% | 14.80% |
EBITDA | 10.42 | 9.18 | 14.42 | 23.65 | 26.04 | 29.65 |
EBITDA Margin | 6.46% | 5.74% | 9.14% | 15.92% | 19.43% | 24.41% |
D&A For EBITDA | 11.72 | 11.51 | 10.86 | 8.57 | 4.71 | 2.79 |
EBIT | -1.3 | -2.33 | 3.56 | 15.08 | 21.33 | 26.86 |
EBIT Margin | -0.80% | -1.46% | 2.26% | 10.15% | 15.92% | 22.12% |
Effective Tax Rate | - | - | - | - | 30.21% | 67.99% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.